Alkermes Plc news

   Watch this stock
Showing stories 1 - 10 of about 94   

Articles published

ALKS 59.92
price chart
Recent Research Analysts' Ratings Changes for Alkermes Plc (ALKS)
5/21/2015 - Alkermes Plc is now covered by analysts at Barclays. They set an “overweight” rating and a $74.00 price target on the stock.
Insider Selling: Alkermes Plc insider Shane Cooke Sells 18000 Shares of ...  sleekmoney
Alkermes' Corporate Presentation to be Webcast at the Jefferies 2015 ...  MarketWatch
Alkermes Plc insider Sells $1085580.00 in Stock (ALKS)
Alkermes Plc logo Alkermes Plc (NASDAQ:ALKS) insider Shane Cooke sold 18,000 shares of the company's stock in a transaction that occurred on Tuesday, May 26th.
Insider Selling: Alkermes Plc SVP Sells $79967.78 in Stock (ALKS)  Mideast Time
Alkermes Plc SVP Sells $1762314.18 in Stock (ALKS)
Alkermes Plc logo Alkermes Plc (NASDAQ:ALKS) SVP Rebecca Peterson sold 28,558 shares of the company's stock in a transaction that occurred on Friday, May 22nd.
Rebecca Peterson Insider Trade for 28558 Shares of Alkermes Plc (NASDAQ ...  OctaFinance.com
Alkermes Plc Receives $67.94 Average PT from Analysts (NASDAQ:ALKS)  sleekmoney
Alkermes Plc (ALKS) Downgraded From Hold to Sell
"We rate ALKERMES PLC (ALKS) a SELL. This is driven by some concerns, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover.
Insider Selling: Alkermes Plc COO Sells $1070850.00 in Stock (ALKS)  The Legacy
Investor Insights on Alkermes PLC (NASDAQ:ALKS)
[Business Wire] Alkermes PLC (NASDAQ:ALKS)(TREND ANALYSIS) announced that its corporate presentation will be webcast live at the UBS Global Healthcare Conference on Monday, May 18, 2015, at 2:00 p.m.
Alkermes Plc Given Average Recommendation of "Hold" by Analysts ...  The Legacy
Q1 Earnings of $-0.14 Anticipated for Alkermes plc (NASDAQ:ALKS)  Markets Daily
Alkermes plc Reports First Quarter 2015 Financial Results
Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio.
Alkermes' (ALKS) CEO Richard Pops on Q1 2015 Results - Earnings Call ...  Seeking Alpha
Stock Technical Report on Alkermes PLC (NASDAQ:ALKS)
Alkermes PLC (NASDAQ:ALKS) (TREND ANALYSIS) shares were traded with no significant volume change. The stock closed last trading session at $55.37, down by -3.37%, with a volume of 1,492,430 shares against an average volume for the last 3 months ...
Alkermes Plc Stock Price Up 5.6% Following Strong Earnings (ALKS)  Dakota Financial News
Alkermes Plc Receives Overweight Rating from JPMorgan Chase & Co. (ALKS)  sleekmoney
Alkermes Plc (NASDAQ:ALKS)'s Stock Insider Deal – Elliot Ehrich Sold 25000 ...
Elliot Ehrich is the EVP - R&D & CMO - Alkermes - Inc. of Alkermes Plc (NASDAQ:ALKS) 61.35 -0.45 -0.73% . He not a long ago made a sale of 25,000 shares in the corporation with the sale value totalling approx.
Alkermes Plc CMO Elliot Ehrich Sells 25000 Shares (ALKS)  The Legacy
Form 4 Alkermes plc. For: May 20 Filed by: LANDINE MICHAEL J
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). 1. Name and Address of Reporting Person *. LANDINE MICHAEL J. (Last), (First), (Middle). 852 WINTER ST. (Street). WALTHAM, MA, 02451 ...
Alkermes plc Announces Sale of Gainesville, GA Manufacturing Facility to Recro ...
Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio.
Alkermes divests Gainesville facility  Atlanta Business Chronicle
Recro Pharma (REPH) to Acquire Alkermes' (ALKS) Gainesville Facility in ...  StreetInsider.com